Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 77, n° 5
pages 978-980 (novembre 2017)
Doi : 10.1016/j.jaad.2017.06.027
Research Letters

Oral tofacitinib monotherapy in Korean patients with refractory moderate-to-severe alopecia areata: A case series

Hyun-Sun Park, MD, PhD a, Min-Woo Kim, MD a, Ji Su Lee, MD a, Hyun-Sun Yoon, MD, PhD a, Chang-Hun Huh, MD, PhD b, Ohsang Kwon, MD, PhD c, Soyun Cho, MD, PhD a,
a Department of Dermatology, Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, Korea 
b Department of Dermatology, Seoul National University Bundang Hospital, Gyeonggi, Korea 
c Department of Dermatology, Seoul National University Hospital, Seoul, Korea 

Reprint requests: Soyun Cho, MD, PhD, 20 Boramae-ro-5-gil, Dongjak-gu, Seoul 07061, Korea20 Boramae-ro-5-gil, Dongjak-guSeoul07061Korea

 Funding sources: None.
 Conflicts of interest: None declared.

Top of the page

© 2017  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline